People: Pharmswellbio Co Ltd (043090.KQ)
043090.KQ on KOSDAQ - Korea Secs Dealers Association Quotation
1,505.00KRW
16 May 2013
1,505.00KRW
16 May 2013
Price Change (% chg)
₩-40.00 (-2.59%)
₩-40.00 (-2.59%)
Prev Close
₩1,545.00
₩1,545.00
Open
₩1,570.00
₩1,570.00
Day's High
₩1,570.00
₩1,570.00
Day's Low
₩1,480.00
₩1,480.00
Volume
289,241
289,241
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Yeong Jin Gwon |
46 | 2008 | Chief Executive Officer, Director |
Seok Du Son |
57 | 2010 | Managing Director |
Yun Tae Gwon |
41 | Managing Director | |
Jae Min Cho |
43 | Assistant Managing Director | |
Bong Hyeon Kim |
47 | 2013 | Director |
Hak Su Kim |
46 | 2009 | Director |
Han Yeong Bae |
41 | 2008 | Non-Executive Independent Director |
Geon Ok Jin |
54 | IR Contact Officer |
Biographies
| Name | Description |
|---|---|
Yeong Jin Gwon |
Gwon Yeong Jin has been Chief Executive Officer and Director of PharmswellBio Co., Ltd. (formerly known as KoBio Tech Co., Ltd) since April 1, 2008. Gwon was preivously Chief Executive Officer of Pharmswell Co.,Ltd. Gwon holds a Master's degree in Management from Korea University. |
Seok Du Son |
Son Seok Du has been Managing Director of PharmswellBio Co., Ltd. (formerly known as KoBio Tech Co., Ltd) since 2010. Son is currently Director of Pharmswell Co.,Ltd. Previously, Son worked for JW PHARMACEUTICAL. Son received a Master's degree in International Trade from Sungkyunkwan University, Korea. |
Yun Tae Gwon |
|
Jae Min Cho |
Cho Jae Min is Assistant Managing Director of PharmswellBio Co., Ltd. Previously, Cho served as Director of DAEHAN NEW PHARM CO., LTD. |
Bong Hyeon Kim |
Kim Bong Hyeon has been Director of PharmswellBio Co., Ltd. since March 28, 2013. Kim currently also serves as Chief Executive Officer in SERVICE-IN CO., LTD. Kim used to be Assistant Managing Director of SK TELECOM CO.,LTD and another Korea-based company. Kim holds a Master's degree in Business Administration from Seoul National University, Korea. |
Hak Su Kim |
Kim Hak Su has been Director of PharmswellBio Co., Ltd since March 30, 2009. Previously, Kim worked for SAMPYO corporation. Kim holds a Bachelor's degree in Commerce from University of Incheon, Korea. |
Han Yeong Bae |
Bae Han Yeong has been Non-Executive Independent Director in PharmswellBio Co., Ltd. since May 7, 2008. Currently, Bae is also a Lawyer in korea. Bae holds a Bachelor's degree in Law from Seoul National University, Korea, and a Master's degree in Law from University of Pennsylvania, the United States. |
Geon Ok Jin |
Jin Geon Ok resigned from the position of Director at PharmswellBio Co., Ltd. (formerly known as KoBio Tech Co., Ltd) in 2009. Jin is currently Managing Director of Pharmswell Co.,Ltd.. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Yeong Jin Gwon |
-- |
Seok Du Son |
-- |
Yun Tae Gwon |
-- |
Jae Min Cho |
-- |
Bong Hyeon Kim |
-- |
Hak Su Kim |
-- |
Han Yeong Bae |
-- |
Geon Ok Jin |
-- |
As Of
Options Compensation
| Name | Options | Value |
|---|---|---|
Yeong Jin Gwon |
0 | 0 |
Seok Du Son |
0 | 0 |
Yun Tae Gwon |
0 | 0 |
Jae Min Cho |
0 | 0 |
Bong Hyeon Kim |
0 | 0 |
Hak Su Kim |
0 | 0 |
Han Yeong Bae |
0 | 0 |
Geon Ok Jin |
0 | 0 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
